Rapid7, Inc. expected to post earnings of 35 cents a share - Earnings Preview
Rapid7, Inc. expected to post earnings of 35 cents a share - Earnings Preview
Rapid7, Inc. RPD.OQ RPD.O is expected to show a fall in quarterly revenue when it reports results on August 10 for the period ending June 30 2026
The Boston Massachusetts-based company is expected to report a 2.8% decrease in revenue to $208.248 million from $214.19 million a year ago, according to the mean estimate from 22 analysts, based on LSEG data.The company's guidance on May 5 2026, for the period ended June 30, was for revenue between $207.00 million and $209.00 million.
LSEG's mean analyst estimate for Rapid7, Inc. is for earnings of 35 cents per share. The company's EPS guidance on May 5 2026, for the period ended June 30, was between $0.33 and $0.36
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 18 "hold" and 4 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Rapid7, Inc. is $8.00, about 22.9% below its last closing price of $10.38
The company's guidance on May 5 2026 for the period ended June 30 was for Earnings before Interest and Taxes between USD24 million and USD26 million.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2026 | 0.30 | 0.30 | 0.36 | Beat | 18.8 |
Dec. 31 2026 | 0.41 | 0.41 | 0.44 | Beat | 7.4 |
Sep. 30 2025 | 0.45 | 0.45 | 0.57 | Beat | 25.9 |
Jun. 30 2025 | 0.44 | 0.44 | 0.58 | Beat | 30.8 |
Mar. 31 2025 | 0.35 | 0.35 | 0.49 | Beat | 42 |
Dec. 31 2024 | 0.50 | 0.50 | 0.48 | Missed | -3.3 |
Sep. 30 2024 | 0.52 | 0.52 | 0.66 | Beat | 27.4 |
Jun. 30 2024 | 0.52 | 0.52 | 0.58 | Beat | 12.5 |
This summary was machine generated August 7 at 20:51 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Rapid7
See all newsBrief: Rapid7 Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
CrowdStrike sparks rally across cybersecurity stocks after upbeat forecast
Brief: Rapid7 Finds Nearly Two-Thirds Of Vulnerabilities Exploited In Q2 2026 Required No User Interaction To Initiate
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics